公开(公告)号：US20160206643A1

公开(公告)日：2016-07-21

申请号：US15025324

申请日：2014-09-29

Applicant: SUNSTAR INC.

Inventor： Youko SONO ,  Makoto SUWA ,  Motonobu MATSUMOTO

IPC: A61K31/7048 ,  A61K36/63 ,  A61K9/00 ,  A61K31/275

CPC classification number: A61K31/7048 ,  A23G4/06 ,  A23G4/068 ,  A23G4/12 ,  A23L2/52 ,  A23L33/10 ,  A23L33/105 ,  A61K9/0053 ,  A61K9/0095 ,  A61K9/2054 ,  A61K9/4866 ,  A61K31/05 ,  A61K31/26 ,  A61K31/275 ,  A61K36/31 ,  A61K36/63 ,  A61K36/76 ,  A61P3/04 ,  A61K2300/00

Abstract: An object of the present invention is to provide an obesity-suppressing composition that suppresses fat accumulation in adipocytes and that has an effect of suppressing body weight gain.The present invention provides an obesity-suppressing composition comprising the following components (A) and (B): (A) at least one member selected from the group consisting of oleuropein and hydroxytyrosol; (B) at least one member selected from the group consisting of sulforaphane compounds and willow extract.

Abstract translation: 本发明的目的是提供一种抑制脂肪细胞中的脂肪蓄积并具有抑制体重增加的作用的肥胖抑制组合物。 本发明提供一种包含以下组分（A）和（B）的肥胖抑制组合物：（A）选自橄榄精和羟基酪醇中的至少一种; （B）选自由萝卜硫素化合物和柳树提取物组成的组中的至少一种。

公开(公告)号：US20170258822A1

公开(公告)日：2017-09-14

申请号：US15606685

申请日：2017-05-26

Applicant: SUNSTAR INC.

Inventor： Youko SONO ,  Makoto SUWA ,  Motonobu MATSUMOTO

IPC: A61K31/7048 ,  A23G4/06 ,  A23G4/12 ,  A23L2/52 ,  A23L33/10 ,  A23L33/105 ,  A61K31/05 ,  A61K31/26 ,  A61K31/275 ,  A61K36/31 ,  A61K36/63 ,  A61K36/76 ,  A61K9/00 ,  A61K9/48 ,  A61K9/20

CPC classification number: A61K31/7048 ,  A23G4/06 ,  A23G4/068 ,  A23G4/12 ,  A23L2/52 ,  A23L33/10 ,  A23L33/105 ,  A61K9/0053 ,  A61K9/0095 ,  A61K9/2054 ,  A61K9/4866 ,  A61K31/05 ,  A61K31/26 ,  A61K31/275 ,  A61K36/31 ,  A61K36/63 ,  A61K36/76 ,  A61P3/04 ,  A61K2300/00

Abstract: An object of the present invention is to provide an obesity-suppressing composition that suppresses fat accumulation in adipocytes and that has an effect of suppressing body weight gain.The present invention provides an obesity-suppressing composition comprising the following components (A) and (B): (A) at least one member selected from the group consisting of oleuropein and hydroxytyrosol; (B) at least one member selected from the group consisting of sulforaphane compounds and willow extract.